CIK 0001674416
- Large accelerated filer
CRISPR Therapeutics AG
Sign in to watch- Ticker
- CRSP
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- Switzerland
- Entity type
- Operating
- EIN
- 473173478
- Phone
- +1 617-315-4600
- Business address
- BAARERSTRASSE 14, ZUG, Switzerland
- Former names
- CRISPR Therapeutics AG
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $4,881,673
- in 7 filings, $1.5M under 10b5-1 plans
Net −$4,881,673. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-02-21 | Smith Brendan Chief Financial Officer | Shares withheld for taxes | −1,392 | $48.26 | $67K | 5,072 |
| 2023-02-18 | Smith Brendan Chief Financial Officer | Exercise or conversion | +3,825 | 6,464 | ||
| 2023-02-18 | Smith Brendan Chief Financial Officer | Exercise or conversion · Restricted Stock Units | −3,825 | 11,475 | ||
| 2022-10-17 | Smith Brendan Chief Financial Officer | Shares withheld for taxes | −1,111 | $55.76 | $62K | 2,639 |
| 2022-10-14 | Smith Brendan Chief Financial Officer | Exercise or conversion | +3,750 | 3,750 | ||
| 2022-10-14 | Smith Brendan Chief Financial Officer | Exercise or conversion · Restricted Stock Units | +3,750 | 11,250 | ||
| 2022-10-07 | Smith Brendan Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +14,000 | 14,000 | ||
| 2022-08-16 | Smith Brendan Chief Financial Officer | Grant or award · Restricted Stock Units | +10,000 | 10,000 | ||
| 2022-02-18 | Smith Brendan Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +30,000 | 30,000 | ||
| 2022-02-18 | Smith Brendan Chief Financial Officer | Grant or award · Restricted Stock Units | +15,300 | 15,300 | ||
| 2021-10-14 | Smith Brendan Chief Financial Officer | Grant or award · Restricted Stock Units | +15,000 | 15,000 | ||
| 2021-10-14 | Smith Brendan Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +90,000 | 90,000 |
Page 1 of 1 · 12 trades